Sandoz has claimed the first FDA approvals for biosimilars of Amgen’s blockbuster bone disease therapy denosumab, but has not said when it plans to launch them onto the US market. Amgen sells RANKL ...
The chart that proves you should stay invested in the US ...
The objective of the Fund is to achieve capital growth and income delivering average annual investment returns (total returns, net of fees) of at least RPI + 2.0% over the long term (which is defined ...
Capacite Infraprojects has won a major contract worth Rs 542.37 crore from IIT Bombay. The project involves constructing fast track buildings using composite steel and reinforced cement concrete. This ...
The objective of the Fund is to achieve capital growth and income delivering average annual investment returns (total returns, net of fees) of at least RPI + 2.0% over the long term (which is defined ...
Heavy rainfall in September disrupted mining operations, leading to a 3.9% year-on-year decline in production for Coal India Ltd (CIL). Despite this dip, the Coal and Mines Minister assured that there ...
To view the latest digital edition click the image on the left.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback